Developer docs
API playgroundTry for free, no card

Search company profiles

Skaaltec

Full company profile

uuid0004hve

Namestring
Skaaltec
Legal namestring
Skaaltec AG
Websiteurl
skaaltec.com
Company typeenum
Private
Founded yearint
2026
Descriptiontext

Skaaltec AG is a Swiss medical device company and ETH Zürich spin-off developing SmartVNS, a non-invasive wearable system for stroke and spinal cord injury rehabilitation. SmartVNS combines a wrist-worn inertial sensor, a neck-worn stimulator with an auricular electrode, and embedded machine learning algorithms that detect functional movements in real time and automatically trigger transcutaneous auricular vagus nerve stimulation (taVNS) at the optimal moment for motor learning consolidation. The product is built on 15+ years of rehabilitation engineering research at ETH Zürich's Rehabilitation Engineering Laboratory (RELab), where the founders (Dr. Paulius Viskaitis and Dr. Dane Donegan) and scientific advisors (Prof. Dr. Olivier Lambercy and Prof. Dr. Roger Gassert) are based.

The company serves two primary customer segments: rehabilitation clinics and hospitals that need scalable delivery of adjunctive neurostimulation therapy, and ultimately stroke survivors needing at-home therapy that augments limited clinical capacity. Clinical validation is anchored by a nine-participant feasibility study at cereneo showing UMUX usability of ~85% and sub-2-minute patient setup, plus peer-reviewed evidence in the Journal of Neuroscience and Journal of NeuroEngineering and Rehabilitation. The system is currently investigational and has no Swissmedic, CE or FDA approval.

Skaaltec's business model is dual-track: hardware sales of the SmartVNS device to clinical buyers, supplemented by a planned companion digital neurorehabilitation platform for therapists and patients that would generate subscription revenue from remote monitoring and therapy management. Go-to-market is enterprise clinical field sales supported by conference presence (RehabWeek, Swiss Medtech Day) and active grant-driven programs (USZ Startup Label, Venture Leaders Medtech 2026, Future of Health Grant, Innosuisse, Bridge, Venture Kick). The company is pre-revenue, headquartered in Bern with R&D in Zürich at Balgrist Campus and ETH GLC.

Short descriptiontext

Skaaltec AG is a Swiss ETH Zürich spin-off building SmartVNS, a non-invasive wearable that pairs vagus nerve stimulation with automated movement detection to enhance stroke and spinal cord injury rehabilitation for clinics and patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBern, Switzerland
HQ citystring
Bern
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurorehabilitation technology, vagus nerve stimulation, stroke rehabilitation devices, non-invasive brain stimulation, wearable medical devices
Industry3 codes
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLAHAEAK
Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Home Health Care Services62161
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code3 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Home Health Care Services8082
Product category
Neurorehabilitation Medical Devices
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SmartVNS Medical Device Sales
TypeHardware Sales
Description

The primary revenue stream will be from the sale of the SmartVNS hardware system to rehabilitation hospitals, clinics, and potentially directly to patients. The device is currently under development and awaiting regulatory approval.

skaaltec.com
2Digital Neurorehabilitation Platform
TypeSubscription Recurring
Description

A companion digital platform for therapists and patients enabling remote monitoring, data analytics, and therapy management. This would likely generate ongoing subscription revenue from healthcare providers or patients using the platform.

skaaltec.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1SmartVNS
Description

Standalone wearable therapy system that boosts recovering brain by activating the vagus nerve without surgery for stroke rehabilitation

skaaltec.com
Core offering1 text field

Skaaltec is developing SmartVNS, a standalone wearable neurorehabilitation system that combines a wrist-worn inertial sensor, a custom neck-worn transcutaneous auricular vagus nerve stimulation (taVNS) stimulator with earpiece electrode, and proprietary algorithms that automatically pair stimulation with functional movements. The system targets post-stroke upper limb motor rehabilitation by activating the brain's vagus nerve pathways to enhance neuroplasticity during therapy. It is designed as plug-and-play for both clinical and independent home use, with planned regulatory clearance (Swissmedic, CE, FDA) and a companion digital platform for therapist monitoring.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 31% increase in motor evoked potential (MEP) amplitudes when TMS pulse coincided with taVNS stimulation during movement
+4 more records
Product overview1 text field

Skaaltec is developing a single unified product called SmartVNS—a standalone wearable therapy system for stroke recovery that combines hardware (wrist-worn motion sensor, neck stimulator, and auricular electrode) with embedded AI algorithms for automated closed-loop neuromodulation. The system is designed for both clinical and home use, featuring automatic movement-triggered vagus nerve stimulation that enhances the brain's natural learning mechanisms during rehabilitation therapy.

Product and service1 record
1SmartVNS
CategoryNeurorehabilitation medical device
Description

A standalone wearable neurorehabilitation system that combines a wrist-worn inertial sensor for real-time movement detection, a custom neck-worn stimulator with auricular electrode for transcutaneous vagus nerve stimulation (taVNS), and automated movement-triggered stimulation that enhances stroke recovery by pairing stimulation with functional movements. Designed for rehabilitation hospitals, clinics, physical therapy centers, and home users to deliver scalable vagus nerve stimulation therapy with remote monitoring.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ETH Zürich is the academic institution of origin for Skaaltec. The company was conceived and developed at the Rehabilitation Engineering Laboratory (RELab) at ETH Zürich, with scientific advisors Prof. Dr. Olivier Lambercy and Prof. Dr. Roger Gassert who have developed rehabilitation solutions for over 15 years.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

RELab at ETH Zürich hosts the Skaaltec team and is the birthplace of SmartVNS technology. The lab provides ongoing research collaboration, access to expertise in rehabilitation engineering, and a pipeline of scientific talent.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner that conducted the feasibility trial with nine participants. Cereneo provides clinical expertise, patient access, and user feedback essential for product development and validation.

Strategic tierCoreTypeTechnology or Integration
Description

Development partner working with Skaaltec on product-level redesign of wearables, internal hardware updates, and EMC (electromagnetic compatibility) evaluation for regulatory approval.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Skaaltec was accepted into USZ Health Innovation Hub and awarded the USZ Startup Label and funding. Provides pathway to deeper collaboration with one of Europe's leading university hospitals.

6DayOne
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Swiss healthcare innovation ecosystem partner supporting Skaaltec's development and market access.

skaaltec.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

AI research center at ETH Zürich providing expertise and resources for machine learning development supporting SmartVNS technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Organizer of Venture Leaders Medtech 2026 program. Selected Skaaltec from over 80 applicants to participate in the 20th anniversary program for Boston market expansion.

Strategic tierMinorTypeGTM or Marketing Partner
Description

European healthcare innovation network partnership through Future of Health Grant to support international expansion, particularly in Paris and Berlin markets.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Healthcare innovation hub partnership through Future of Health Grant to support market access in Spain.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

New strategic partnership announced for the Future of Health Grant program to support clinical validation and pilot projects.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

electroCore is the most direct competitor: it commercializes gammaCore, a non-invasive vagus nerve stimulation (nVNS) device. Skaaltec competes on the same core mechanism (non-invasive auricular VNS for neurological indications) but differentiates via closed-loop, movement-paired stimulation and a stroke-rehab-specific positioning.

TypeDirect peer
Description

MindMaze builds digital therapeutics and neurorehabilitation platforms (e.g., MindMotion) targeting stroke and brain-injury recovery in hospitals and at home. Like Skaaltec, it combines motion sensors, gamified therapy, and clinical evidence to drive motor recovery — a directly comparable digital-neurorehabilitation approach.

TypeDirect peer
Description

Parasym develops a non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) device targeting similar autonomic and neurological indications. Direct overlap with Skaaltec's core taVNS technology, though with a less rehab-focused positioning.

4Sword Health
TypeDirect peer
Description

Sword Health is a digital musculoskeletal and rehabilitation platform combining sensor-guided exercise with remote clinician oversight. It is comparable to Skaaltec in business model (hardware/software subscription, virtual rehab delivery) and in targeting MSK and post-stroke recovery, though without the neuromodulation component.

TypeDirect peer
Description

Hinge Health operates a digital MSK and rehabilitation platform sold to employers and payers, with wearable motion sensors enabling remote exercise therapy. Comparable in business model, sensor-driven therapy approach, and payer-facing GTM motion, although Hinge Health focuses on MSK pain rather than neurological rehabilitation.

TypeDirect peer
Description

Saebo is a leading specialty manufacturer of upper-limb rehabilitation devices and orthoses used by stroke survivors and OTs/PTs in clinics and at home. Directly comparable target customer (stroke patients with upper-limb impairment) and channel (rehabilitation clinics), though Saebo's portfolio is mechanical/orthotic rather than neurostimulation-based.

7Bionik Laboratories
TypeDirect peer
Description

Bionik Laboratories develops robotic rehabilitation technologies (e.g., InMotion ARM) for stroke and upper-limb recovery. Comparable clinical use case (post-stroke upper-limb motor recovery) and customer base (rehabilitation hospitals), though using robotics rather than closed-loop neuromodulation.

TypeRegional player
Description

Tyromotion is an Austrian/German manufacturer of robotic and sensor-based rehabilitation devices for neurological and orthopedic indications. Comparable clinical use case and clinic-channel GTM, though primarily active in DACH-region hospital sales and using robotics rather than neuromodulation.

TypeBroad incumbent
Description

Penumbra is an established neurovascular device company that has expanded into neuro-recovery and neuromodulation via its REAL System and immersive rehabilitation portfolio. Comparable end-customer (stroke rehab hospitals) and adjacent product category, but operates at much larger scale across a broader device portfolio.

TypeEmerging player
Description

Kaia Health delivers app-based digital MSK and chronic-pain therapy, combining computer-vision exercise feedback with behavioral coaching. Comparable as a digital-rehabilitation therapeutic with sensor-driven, software-led delivery, but focused on MSK pain rather than post-stroke motor recovery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Skaaltec

Neurorehabilitation Medical Devicesskaaltec.com

Skaaltec AG is a Swiss ETH Zürich spin-off building SmartVNS, a non-invasive wearable that pairs vagus nerve stimulation with automated movement detection to enhance stroke and spinal cord injury rehabilitation for clinics and patients.

What Skaaltec does

Skaaltec AG is a Swiss medical device company and ETH Zürich spin-off developing SmartVNS, a non-invasive wearable system for stroke and spinal cord injury rehabilitation. SmartVNS combines a wrist-worn inertial sensor, a neck-worn stimulator with an auricular electrode, and embedded machine learning algorithms that detect functional movements in real time and automatically trigger transcutaneous auricular vagus nerve stimulation (taVNS) at the optimal moment for motor learning consolidation. The product is built on 15+ years of rehabilitation engineering research at ETH Zürich's Rehabilitation Engineering Laboratory (RELab), where the founders (Dr. Paulius Viskaitis and Dr. Dane Donegan) and scientific advisors (Prof. Dr. Olivier Lambercy and Prof. Dr. Roger Gassert) are based.

The company serves two primary customer segments: rehabilitation clinics and hospitals that need scalable delivery of adjunctive neurostimulation therapy, and ultimately stroke survivors needing at-home therapy that augments limited clinical capacity. Clinical validation is anchored by a nine-participant feasibility study at cereneo showing UMUX usability of ~85% and sub-2-minute patient setup, plus peer-reviewed evidence in the Journal of Neuroscience and Journal of NeuroEngineering and Rehabilitation. The system is currently investigational and has no Swissmedic, CE or FDA approval.

Skaaltec's business model is dual-track: hardware sales of the SmartVNS device to clinical buyers, supplemented by a planned companion digital neurorehabilitation platform for therapists and patients that would generate subscription revenue from remote monitoring and therapy management. Go-to-market is enterprise clinical field sales supported by conference presence (RehabWeek, Swiss Medtech Day) and active grant-driven programs (USZ Startup Label, Venture Leaders Medtech 2026, Future of Health Grant, Innosuisse, Bridge, Venture Kick). The company is pre-revenue, headquartered in Bern with R&D in Zürich at Balgrist Campus and ETH GLC.

Skaaltec firmographics

Firmographics
Name
Skaaltec
Legal name
Skaaltec AG
Website
https://skaaltec.com
Company type
Private
Founded year
2026
Operating status
Operating
Headcount range
1–10 employees
Short description
Skaaltec AG is a Swiss ETH Zürich spin-off building SmartVNS, a non-invasive wearable that pairs vagus nerve stimulation with automated movement detection to enhance stroke and spinal cord injury rehabilitation for clinics and patients.
Ownership category
akta.pro rank

Skaaltec industry classification

Industry
Product category
Neurorehabilitation Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLAHAEAK
Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

  • Neurorehabilitation technology
  • Vagus nerve stimulation
  • Stroke rehabilitation devices
  • Non-invasive brain stimulation
  • Wearable medical devices

Where Skaaltec is headquartered

Location

Headquarters

HQ city
Bern
HQ country
Switzerland
HQ region
Europe

Offices3 records

Markets served

Skaaltec business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. SmartVNS Medical Device Sales: The primary revenue stream will be from the sale of the SmartVNS hardware system to rehabilitation hospitals, clinics, and potentially directly to patients. The device is currently under development and awaiting regulatory approval.
  2. Digital Neurorehabilitation Platform: A companion digital platform for therapists and patients enabling remote monitoring, data analytics, and therapy management. This would likely generate ongoing subscription revenue from healthcare providers or patients using the platform.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Skaaltec product offering

Product offering

Core offering

Skaaltec is developing SmartVNS, a standalone wearable neurorehabilitation system that combines a wrist-worn inertial sensor, a custom neck-worn transcutaneous auricular vagus nerve stimulation (taVNS) stimulator with earpiece electrode, and proprietary algorithms that automatically pair stimulation with functional movements. The system targets post-stroke upper limb motor rehabilitation by activating the brain's vagus nerve pathways to enhance neuroplasticity during therapy. It is designed as plug-and-play for both clinical and independent home use, with planned regulatory clearance (Swissmedic, CE, FDA) and a companion digital platform for therapist monitoring.

Product overview

Skaaltec is developing a single unified product called SmartVNS—a standalone wearable therapy system for stroke recovery that combines hardware (wrist-worn motion sensor, neck stimulator, and auricular electrode) with embedded AI algorithms for automated closed-loop neuromodulation. The system is designed for both clinical and home use, featuring automatic movement-triggered vagus nerve stimulation that enhances the brain's natural learning mechanisms during rehabilitation therapy.

Differentiator

Problem solved

Functional benefit

Brands

  • SmartVNS: Standalone wearable therapy system that boosts recovering brain by activating the vagus nerve without surgery for stroke rehabilitation

Products and services

  • SmartVNS A standalone wearable neurorehabilitation system that combines a wrist-worn inertial sensor for real-time movement detection, a custom neck-worn stimulator with auricular electrode for transcutaneous vagus nerve stimulation (taVNS), and automated movement-triggered stimulation that enhances stroke recovery by pairing stimulation with functional movements. Designed for rehabilitation hospitals, clinics, physical therapy centers, and home users to deliver scalable vagus nerve stimulation therapy with remote monitoring.

Quantifiable outcome

  • 31% increase in motor evoked potential (MEP) amplitudes when TMS pulse coincided with taVNS stimulation during movement
  • +4 more outcomes

Companies that use Skaaltec

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Skaaltec technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Skaaltec partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • ETH ZürichcoreStrategic or Co-development PartnerETH Zürich is the academic institution of origin for Skaaltec. The company was conceived and developed at the Rehabilitation Engineering Laboratory (RELab) at ETH Zürich, with scientific advisors Prof. Dr. Olivier Lambercy and Prof. Dr. Roger Gassert who have developed rehabilitation solutions for over 15 years.
  • Rehabilitation Engineering Laboratory (RELab)coreStrategic or Co-development PartnerRELab at ETH Zürich hosts the Skaaltec team and is the birthplace of SmartVNS technology. The lab provides ongoing research collaboration, access to expertise in rehabilitation engineering, and a pipeline of scientific talent.
  • cereneocoreStrategic or Co-development PartnerClinical partner that conducted the feasibility trial with nine participants. Cereneo provides clinical expertise, patient access, and user feedback essential for product development and validation.
  • HelblingcoreTechnology or IntegrationDevelopment partner working with Skaaltec on product-level redesign of wearables, internal hardware updates, and EMC (electromagnetic compatibility) evaluation for regulatory approval.
  • University Hospital Zurich (USZ) Health Innovation HubcoreStrategic or Co-development PartnerSkaaltec was accepted into USZ Health Innovation Hub and awarded the USZ Startup Label and funding. Provides pathway to deeper collaboration with one of Europe's leading university hospitals.
  • DayOneminorStrategic or Co-development PartnerSwiss healthcare innovation ecosystem partner supporting Skaaltec's development and market access.
  • ETH AI CenterminorStrategic or Co-development PartnerAI research center at ETH Zürich providing expertise and resources for machine learning development supporting SmartVNS technology.
  • VenturelabcoreStrategic or Co-development PartnerOrganizer of Venture Leaders Medtech 2026 program. Selected Skaaltec from over 80 applicants to participate in the 20th anniversary program for Boston market expansion.
  • Future4careminorGTM or Marketing PartnerEuropean healthcare innovation network partnership through Future of Health Grant to support international expansion, particularly in Paris and Berlin markets.
  • Barcelona & Madrid Health HubminorGTM or Marketing PartnerHealthcare innovation hub partnership through Future of Health Grant to support market access in Spain.
  • Ensemble Hospitalier de la CôteminorStrategic or Co-development PartnerNew strategic partnership announced for the Future of Health Grant program to support clinical validation and pilot projects.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Skaaltec competitors and assessment

Company assessment

Direct peers

  • electroCore: electroCore is the most direct competitor: it commercializes gammaCore, a non-invasive vagus nerve stimulation (nVNS) device. Skaaltec competes on the same core mechanism (non-invasive auricular VNS for neurological indications) but differentiates via closed-loop, movement-paired stimulation and a stroke-rehab-specific positioning.
  • MindMaze: MindMaze builds digital therapeutics and neurorehabilitation platforms (e.g., MindMotion) targeting stroke and brain-injury recovery in hospitals and at home. Like Skaaltec, it combines motion sensors, gamified therapy, and clinical evidence to drive motor recovery — a directly comparable digital-neurorehabilitation approach.
  • Parasym: Parasym develops a non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) device targeting similar autonomic and neurological indications. Direct overlap with Skaaltec's core taVNS technology, though with a less rehab-focused positioning.
  • Sword Health: Sword Health is a digital musculoskeletal and rehabilitation platform combining sensor-guided exercise with remote clinician oversight. It is comparable to Skaaltec in business model (hardware/software subscription, virtual rehab delivery) and in targeting MSK and post-stroke recovery, though without the neuromodulation component.
  • Hinge Health: Hinge Health operates a digital MSK and rehabilitation platform sold to employers and payers, with wearable motion sensors enabling remote exercise therapy. Comparable in business model, sensor-driven therapy approach, and payer-facing GTM motion, although Hinge Health focuses on MSK pain rather than neurological rehabilitation.
  • Saebo: Saebo is a leading specialty manufacturer of upper-limb rehabilitation devices and orthoses used by stroke survivors and OTs/PTs in clinics and at home. Directly comparable target customer (stroke patients with upper-limb impairment) and channel (rehabilitation clinics), though Saebo's portfolio is mechanical/orthotic rather than neurostimulation-based.
  • Bionik Laboratories: Bionik Laboratories develops robotic rehabilitation technologies (e.g., InMotion ARM) for stroke and upper-limb recovery. Comparable clinical use case (post-stroke upper-limb motor recovery) and customer base (rehabilitation hospitals), though using robotics rather than closed-loop neuromodulation.

Regional players

  • Tyromotion: Tyromotion is an Austrian/German manufacturer of robotic and sensor-based rehabilitation devices for neurological and orthopedic indications. Comparable clinical use case and clinic-channel GTM, though primarily active in DACH-region hospital sales and using robotics rather than neuromodulation.

Broad incumbents

  • Penumbra: Penumbra is an established neurovascular device company that has expanded into neuro-recovery and neuromodulation via its REAL System and immersive rehabilitation portfolio. Comparable end-customer (stroke rehab hospitals) and adjacent product category, but operates at much larger scale across a broader device portfolio.

Emerging players

  • Kaia Health: Kaia Health delivers app-based digital MSK and chronic-pain therapy, combining computer-vision exercise feedback with behavioral coaching. Comparable as a digital-rehabilitation therapeutic with sensor-driven, software-led delivery, but focused on MSK pain rather than post-stroke motor recovery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

Skaaltec social profiles

Digital presence

Skaaltec compliance and trust

Trust signal

Compliance7 records

Skaaltec financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Skaaltec leadership team

Management profile

Number of profiles

Profiles6 records

Skaaltec funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Skaaltec M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Skaaltec

What does Skaaltec do?

Skaaltec is developing SmartVNS, a standalone wearable neurorehabilitation system that combines a wrist-worn inertial sensor, a custom neck-worn transcutaneous auricular vagus nerve stimulation (taVNS) stimulator with earpiece electrode, and proprietary algorithms that automatically pair stimulation with functional movements. The system targets post-stroke upper limb motor rehabilitation by activating the brain's vagus nerve pathways to enhance neuroplasticity during therapy. It is designed as plug-and-play for both clinical and independent home use, with planned regulatory clearance (Swissmedic, CE, FDA) and a companion digital platform for therapist monitoring.

Is Skaaltec a public or private company?

Skaaltec is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Skaaltec founded?

Skaaltec was founded in 2026. It employs 1 to 10 people.

Where is Skaaltec based?

Skaaltec is headquartered in Bern, Switzerland, in the Europe region.

How does Skaaltec make money?

Two revenue lines are on record. SmartVNS Medical Device Sales are the primary driver. The others are digital Neurorehabilitation Platform.

Who are Skaaltec's main competitors?

Direct peers on record are electroCore, MindMaze, Parasym, Sword Health, Hinge Health, Saebo and Bionik Laboratories. Tyromotion is listed as a regional player. Penumbra is listed as a broad incumbent. Kaia Health is listed as an emerging player.

Does Skaaltec have an API?

No public API is recorded for Skaaltec.

What industry is Skaaltec in?

Skaaltec's product category is Neurorehabilitation Medical Devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals